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Abstract 
Background:  Drug-resistance for depression and anxiety is a major limitation in the 
treatment of these common disorders, and adjunct support interventions may be beneficial in 
the treatment of these patients.    
Aims: The purpose of this study was to evaluate the effects of a short-term (8 session) 
Relaxation Response Skills Training (RRST) programme for a population of psychiatric 
outpatients with anxiety and mood disorders who were unresponsive to drug treatment, and to 
test the feasibility of this intervention as complementary treatment for a psychiatric setting. 
Methods: Forty patients were measured for overall psychopathological symptoms, 
depression, and anxiety, and were then given an 8-week course of RRST, while continuing 
their pharmacological treatment.  Following the RRST intervention, participants were again 
assessed. 
Results: The results demonstrated reductions in overall symptoms (large effect size 
and reasonable clinically significant change), and also in depression and anxiety (medium 
effect sizes and clinically significant change).   
Conclusions: These results suggest that this short-term RRT offers a simple and cost-
effective way to augment drug management for participants with common psychiatric 
disorders who are less responsive to the drug treatment. 
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Anxiety and Mood Disorders are among the most prevalent psychiatric conditions that 
require treatment (Mathers & Loncar, 2006; Merikangas et al., 2010), and the associated 
problems are the most relevant of the symptoms that lead to referral to psychiatric units 
(Costello et al., 2011).  Psychopharmacological treatment is highly common for these patients 
(Hollingworth, Burgess, & Whiteford, 2010), but this approach has been noted to have a 
variable set of outcomes (Fournier et al., 2010; Pigott et al., 2010; Trivedi et al., 2006).  In 
particular, there are individuals who, for a variety of reasons, such as noncompliance (Mahler 
et al., 2010) or drug-resistance (Scelzo et al., 2011), do not respond to pharmacological 
regimes for depression and anxiety disorders (Cukor et al., 2009).  Such non-responsiveness 
is suggested to be as a high as 66% in terms of failure to fully respond to drug treatment, and 
around 50% in terms of only partial reduction of depressive symptoms (Trivedi et al., 2006).  
Given the prevalence of anxiety and depression, and the degree to which many patients 
exhibit drug resistance, developing cost-effective effective psychological interventions, either 
as an alternative or complement to pharmacological treatment, is a clear need for publically-
funded psychiatric services (Kocsis et al., 2009; Wiles et al., 2013). 
There are many well-tested and well-documented psychological interventions for 
depression and anxiety, such as Cognitive Behaviour Therapy (CBT; Wiles et al., 2013) and 
Acceptance and Commitment Therapy (Hayes, Strosahl, & Wilson, 2012).  These types of 
programme have had demonstrable impact on the symptoms reported by individuals with 
depression and anxiety (Coull & Morris, 2011; Cuijpers et al., 2013).  Moreover, there is 
evidence that CBT can provide some degree of benefit if used as a complementary support 
for pharmacological treatment in drug-resistant patients (Wiles et al., 2013).  However, this 
beneficial effect of adjunct psychological support is by no means universally found, with 
some reports failing to note any benefit of psychological treatment to drug-resistant patients 
over and above altered pharmacological regimes (Kocsis et al., 2009), and some reports 
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suggesting that patients will respond to either to pharmacological or to psychological 
interventions when they presented separately (Schatzberg et al., 2005). 
In addition to this mixed pattern of results, a further drawback to the implementation 
of programmes, such as CBT in publically-funded healthcare systems is their typical one-to-
one delivery, and the consequent relative financial expense and shortage of trained 
professionals (Gunter & Whittal, 2010).   For example, in one report (Wiles et al., 2013), 
drug-resistant individuals required between 6 to18 sessions of individual CBT (each session 
lasting 50-60 minutes), in addition to their usual pharmacological care from their medical 
practitioner.  The relative cost of such an intensive treatment may prove somewhat restrictive 
in terms of offering this precise form of adjunct psychological support for drug-resistant 
patients.  In fact, it has been noted that there is no greater benefit from a full CBT approach 
relative to a brief supportive psychotherapy programme, with individual session being much 
shorter (Kocsis et al., 2009). 
There are, however, a range of psychosocial treatments whose characteristics may 
overcome some of the financial drawbacks of full CBT programmes, and which could be 
investigated as complementary interventions in medical and mental health settings.  For 
example, and the use of relaxation-based approaches has grown over the last twenty years 
(Lee et al., 2007), and these approaches can easily be applied in group settings which may 
prove more cost-effective (Dickson-Spillmann et al., 2012; McGillivray & Evert, 2014; 
Turner, 1982).  Moreover, outcome-effectiveness evidence has demonstrated such relaxation-
based approaches to have some efficaciousness across a range of clinical conditions, 
including anxiety (Borkovec & Costello, 1993) and depression (Jorm, Morgan, & Hetrick, 
2008; McGillivray & Evert, 2014). 
 One such intervention strategy is the Relaxation Response Skills Training (RRST) 
programme, which has been employed for the treatment of a broad set of clinical conditions 
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that take stress as common factor and focus of the treatment (Benson, Beary, & Carol, 1974).  
RRST is a self-regulatory integrated approach to stress reduction and emotion management 
that includes relaxation training, cognitive restructuring, mindfulness, and meditative 
techniques.   As this procedure can be applied easily in a group setting (Truzoli et al., 2011), 
it was thought worthwhile to document its impact on outcomes of depressed and anxious 
patients who had displayed drug-resistance.  The RRST procedure is a multi-factorial 
intervention (Benson et al., 1974), based on an integration of psychological and meditative 
approaches to both change and acceptance, sharing much in common with other relaxation 
based approaches (Borkovec & Costello, 1993; Jorm et al., 2008).  Several studies have 
indicated the potential effectiveness of the RRST programme for disorders such as 
hypertension (Benson, Alexander, & Feldman, 1975; McConville, Dusek, & Dusek, 2012), 
and obsessive compulsive disorder (Twohig et al., 2010), but there have been few 
investigations for the most commonly occurring problems such as depression and anxiety. 
Given this, the current study aimed to investigate the efficacy of a group-based RRST 
approach for a homogeneous set (anxiety and depression) of drug-resistant patients.  
Benchmarking studies (McEvoy & Nathan, 2007) concerning the effectiveness of group-
based CBT approaches for heterogeneous clinical groups have demonstrated that: there is a 
wide effect-size range of 0.5 to 3.5, with a mean of about 1.0; about 30% of participants 
achieve reliable change, and 10% achieve clinically significant change.  These figures may be 
somewhat higher than those that are typically seen for drug resistant patients offered CBT, 
who show effect sizes of around .7 (Wiles et al., 2013).  A further point of note taken up by 
the current study is that most of these efficacy studies have used patient self-report measures 
of depression and anxiety (e.g., Beck’s Depression and Anxiety Inventories), and the current 
study also employed clinician-rated measures of these problems (i.e., the Hamilton Scales).     
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Method 
Participants 
A sample of 40 patients (11 male and 29 female) who were consecutively referred to a 
psychiatric unit in a teaching hospital a large Italian city were studied.  The patients had a 
mean age of 48.50 (+ 13.15; range = 19 – 69) years old: males = 50.27 (+ 14.46; range = 24 – 
69); females = 47.83 (+ 12.82; range = 19 – 69). 
All patients had a diagnoses, made by a Psychiatrist independent to this study using 
the DSM-IV-TR, of either an anxiety (N = 16; 3 male; 13 female; mean age = 49.31 + 14.86, 
range = 19 – 69) – 14 Generalized Anxiety Disorder, 1 Adjustment Disorder, 1 Anxiety 
Disorder No Specification; or depressive disorder (N = 24; 8 male; 16 female; mean age = 
47.96 + 12.12, range = 26 – 69) – 16 Anxious Depressive Syndrome, 5 Major Depressive 
Recurrent, 1 Dysthymic Disorder, 1 Bipolar Disorder II, 1 Bipolar disorder No Other 
Specification.  All psychiatric diagnoses were made through psychiatric interview, without 
the use of psychiatric tests.  The study excluded any patients referred with Axis II co-
morbidities. 
The patients had been referred to the Psychology unit by their Psychiatrist as they 
were only partially responsive to pharmacological treatment (21 had been treated with an 
SSRI; and 19 with an SNRI).  The inclusion criteria were that patients: (i) showed only a 
small improvement (between 20% and 50%) on the Hamilton Depression Scale and the 
Hamilton Anxiety Rating Scale; (ii) had no symptom reduction or remission over 75% to 
100% of the Hamilton Scales; (iii) had the same level of symptoms for greater than 6 months; 
(iv) had received at least two cycles of drug treatment with an adequate duration and dosage 
for each treatment as indicated by current guidelines; and (v) had been receiving the 
pharmacological treatment for a mean of three months prior to their referral to the Psychiatric 
outpatients unit.  The judgment of partial responsiveness was based on previous guidelines 
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(Kennedy et al., 2009), and consistent with the guidelines of the U.K. National Institute for 
Health Care Excellence (NICE, 2009; 2013).  
 
Materials 
Symptom Checklist 90 (SCL-90; Derogatis, 1992) is a 90-item self-report instrument 
evaluating a range of psychopathological symptoms: somatization, obsessive-compulsive, 
interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and 
psychoticism.  The sum of the items produces the Global Severity Index (GSI) for overall 
psychological distress with an internal reliability (Cronbach ) of .97 (Prinz et al., 2013).  
Factor analytic studies of the Italian version have suggested use of the GSI is most optimal as 
a measure of symptom distress (Prunas et al., 2012).  A clinical cut-off point of a T-score of 
63 is suggested for the overall scale (Derogatis, 1992), which corresponds to the 90th 
percentile for the appropriate nonclinical population.  Non-clinical Italian populations have 
been found to have a mean overall score of 36 (DiMaggio et al., 2011), suggesting a clinical 
cut-off of 73. 
Hamilton Depression and Anxiety Scales (HAMD; Hamilton, 1960, & HAMA, 
Hamilton, 1969) the HAMD is a 21-item clinician-administered questionnaire that indicates 
depression.  Scores of 8 or higher indicate depression, and a non-clinical Italian sample has 
been found to have a mean of 3.5 (Scimeca et al., 2014).  The scale has an internal reliability 
(Cronbach α) of between 0.97 (Bagby et al., 2004). 
The HAMA is a 14-item clinician-administered questionnaire indicating anxiety.  
Scores of 8 or higher indicate anxiety (Bjelland et al., 2002), and a non-clinical Italian sample 
has been found to have a mean of 3.6 (Scimeca et al., 2014).  The scale has an internal 
reliability (α) of between .96 (Bruss et al., 1994).  
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Beck Depression Inventory (BDI; Beck et al., 1961) is a 21-item self-report 
questionnaire that assesses the clinical symptoms of depression over the past week.  The 
score is a sum of the positive answers, ranging from 0 to 63, and it is suggested that scores of 
14 or greater reflect the presence of depression.  Non-clinical Italian samples have been 
found to score 10.5 (DiMaggio et al., 2014).  The internal reliability (of the scale is .92 
(Beck et al., 1988). 
Spielberger Trait Anxiety Inventory (STAI-T; Spielberger, 1983) rates the affective, 
cognitive, and physiological manifestations of anxiety in terms of long-standing patterns (i.e., 
trait anxiety).  Scores for each question range from 1 = never, to 4 = almost always, and the 
total score can range from 20 to 80.  A score of greater than 45 is recommended as showing 
signs of anxiety.  Non-clinical Italian samples have been found to score 43 on the STAI 
(DiMaggio et al., 2014).  The internal reliability ( of the scale is .93 (Spielberger, 1983).  
 
Intervention 
 The programme was modelled after, but not affiliated with, the clinical programmes 
of the Benson-Henry Institute for Mind Body Medicine at Massachusetts General Hospital.  
Patients were taught a variety of techniques aimed at helping with their psychological 
symptoms and as a self-regulatory integrated approach to stress reduction and emotion 
management including: relaxation (Relaxation Response); cognitive restructuring techniques; 
and mindfulness and meditative techniques. 
The training was delivered in 8-weekly, 2-hour group sessions (with a 10-min break 
in the middle); with a one-hour intake individual assessment session, and a one-hour post-
treatment individual assessment session.  Each session was run by two co-therapists: a 
psychologist and a psychiatrist.  In each session, the time was split approximately evenly 
between didactic education and discussion and practice of the targeted skills.    
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During Session 1, the participants were taught about the concepts of stress, coping, 
and the role of breathing in helping reduce stress.  After the break there was a focus on 
diafragmatic breathing, and a debriefing about the contents of the session.  In Session 2, there 
was a focus on the psychophysiology of stress and relaxation, followed by an introduction to 
a number of relaxation exercises.  In Session 3, there was an introduction to the 
psychophysiology of emotions, followed by instruction and training in a mindfulness exercise 
(typically focused breathing).  In Session 4, there were life-style and physical activity 
assessment, followed by the introduction of a meditation exercise.  In Session 5, there were 
lessons on life style and nutrition, followed by a contemplation exercise.  Session 6 included 
a stress and cognitive structuring exercises, followed by further instruction and practice of 
relation exercises.  Session 7 focused on resilience and protective factors related to anxiety 
and depression, followed by a relaxation exercise.  Finally, Session 8 dealt with resources 
about relapse prevention and further relaxation exercises. 
 
Procedure 
 On referral to the unit the patients were all given information relating to the 
programme and study, and gave their informed consent to participate in accordance with the 
Ethical Approval given by the hosting hospital.  During the first individual assessment 
session (prior to the group sessions commencing), the patients were all given a battery of 
psychological tests, including the SCL-90, HAMD, HAMA, BDI, and STAI.  They then 
participated in the eight-week RRST programme, as detailed above, receiving one 2-hour 
group-based RRST session a week for 8 weeks.  Following completion of the intervention, 
the patients were again given the tests during the final assessment session and were debriefed 
regarding the study. 
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Results 
Table 1  
All patients completed the programme (i.e. attended all of the sessions).  Table 1 
shows the mean numbers of symptoms (SCL-90), depression scores (BDI and Hamilton), and 
anxiety scores (STAI and Hamilton), for the sample pre- and post-intervention, and the mean 
change (post-treatment minus pre-treatment scores) across the programme.  Table 1 also 
shows the significance of this change assessed by a paired t-test, and the effect size (d) for 
this value. 
Inspection of the pre-intervention scores shows that the mean number of symptoms 
was higher than the suggested clinical cut-off, as were the self-rated (BDI) and clinician-rated 
(HAMD) depression scores.  Similarly, the mean self-rated (STAI) and clinician-rated 
(HAMA) anxiety scores were higher than the cut-off point for the presence of anxiety.  After 
treatment, all scores had decreased below the respective cut-off points for moderate clinical 
severity.  These reductions were statistically significant for all of the measures, with there 
being large effect-sized decreases according to established criteria50 for the overall 
symptoms, and for clinician-rated depression and anxiety.  Table 1 displays correlations 
between both age and gender and change scores.  In no cases were the changes in the 
outcome variables significantly related to the potential predictors, all ps>.06. 
Tables 2 and 3  
 The changes scores for patients with depressive (Table 2) or anxiety (Table 3) 
disorders show broadly similar patterns to that for the overall sample.  There were slightly 
greater effect sizes for the impact of the treatment on participants with a depressive disorder 
(Table 2) compared to those with an anxiety (Table 3) disorder.  
Table 4 
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Table 4 shows the percentage of participants in the overall sample, and also the 
percentage of participants with a depressive or anxiety disorder, showing improvement in 
symptoms following the intervention.  Four measures of improvement were taken: the simple 
change in the raw score for the various scales; the statistically reliable change51; a change 
from above to below the published cut off for the scale for mild symptoms; and a change 
from above to below the level calculated to be clinically significant using a movement to the 
non-clinical side of the point halfway between 2 standard deviations away from the clinical 
mean and within two standard deviations of the non-clinical mean51.   In calculating these 
values the sample mean was used along with the normative means for non-clinical Italian 
samples given above, and the reliability scores given above.   
Inspection of these data shows that overall symptoms (SCL-90) improved for the 
majority of participants, but that this change was important (reliable or clinically-significant) 
in around 30 to 40% of patients.  There was a greater impact on patients who were depressed 
than those who were anxious, with around 50% of depressed patients improving compared to 
around 25% of anxious patients.  A greater proportion of patients noted self-reported 
clinically-significant recovery for depression (25-50%) than for anxiety (< 10%).  However, 
when clinician-rated clinically-significant changes were assessed, around 50-60% showed 
clinically-significant improvement for anxiety compared to around 15% for depression. 
In terms of symptoms of depression, the change was similar for depressed and 
anxious patients for self-reported symptoms, but was greater for depressed than for anxious 
patients in terms of clinician-rated symptoms.  In terms of anxiety symptoms, a greater 
percentage of depressed patients showed important change compared to anxious patients – a 
trend which was more pronounced for the clinician-rated symptoms. 
Figure 1  
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In order to determine if the treatment impacted on specific symptom types, the change 
in the subscales of the SCL-90 were examined.  Figure 1 shows the mean change in the 
scores for the sub-scales of the SCL-90 for the sample overall, and for the patients with 
depressive or anxiety disorders.  These scores represent the total for the sub-scale divided by 
the number of questions in that scale (i.e., they are the mean score per item).  These change 
scores were analyzed using paired t-tests against zero change, while adopting a Bonferonni 
correct (0.05/9 = 0.0055) for significance.  For the sample overall,  Somatization, 
t(39)=5.35,p<.001 d=.85; Obsessive compulsive, t(39)=6.52,p<.001,d=1.03; Interpersonal 
Sensitivity, t(39)=5.06,p<.001,d=.80; Depression, t(39)=5.19,p<.001,d=.82; Anxiety, 
t(39)=6.02,p<.001,d=.95; and Paranoid Ideation, t(39 =3.17,p<.003,d=.51, were all 
statistically reliable.  For patients with depression the scales for: Somatization, 
t(23)=5.40,p<.001,d=1.10; Obsessive compulsive, t(23)=4.68,p<.001,d=.95; Interpersonal 
Sensitivity, t(23)=4.79,p<.001,d=.98; Depression, t(23)=4.65,p<.001,d=.95; Anxiety, 
t(23)=5.55,p<.001,d=1.13; and Phobic Anxiety, t(23)=3.08,p<.006,d=.63, were all 
statistically reliable.  For patients with anxiety, only the change for Obsessive Compulsive 
symptoms, t(15)=4.50,p<.001,d=1.12, reached the corrected level of statistical significance. 
 
Discussion 
The results demonstrated that the treatment had good patient acceptability, with none 
of the cohort dropping out of the treatment programme.  This is a striking feature of the data, 
and it is unclear whether this aspect is specific to the therapists/setting employed here, or 
would generalise to other settings.  There was a reduction in overall levels of symptoms 
measured by the SCL-90, and patients showed moderate improvement in their depression and 
anxiety.  The effect sizes and the levels of reliable and clinically-significant change for this 
treatment are somewhat lower than those seen for group-based CBT for non-drug resistant 
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patients with a mixed set of symptoms (Nakao et al., 2001), but they are comparable with 
those data reported in previous studies of the impact of CBT on drug-resistant patients (Wiles 
et al., 2013); the moderate effect sizes of the current study were broadly similar to those seen 
in previous studies of psychological support for drug-resistant patients (Wiles et al., 2012).  
However, these improvements were the result of group-based rather than individual sessions, 
which may offer benefit in terms of cost-effectiveness, and also are in line with findings that 
suggest full CBT is not more effective than brief supporting psychotherapy (Kocsis et al., 
2009). 
The impact of the current RRST programme was greater for depression than for 
anxiety, which is also in line with previous investigations of the effect of group-based 
relaxation programmes (McGillivray & Evert, 2014).  The reasons for this pattern of results 
require further exploration, but may include the social support offered to individuals in group 
sessions, which is known to help alleviate depressive symptoms (Cohen & Wills, 1985).  
There were some differences between the degree to which symptoms were shown to be 
improved according to clinician-rated and patient-rated scales.  Although, the former tended 
to show greater effect sizes, it may be the latter which are ultimately more important in terms 
of client-rated success of the programme.  The reasons for the discrepancies will likely 
include the slightly different foci of the questionnaires used by clinicians and patients, but 
may also include the degree to which particular symptoms may be regarded as important to 
the patents in their own functioning, and possible rater bias (and future studies may want to 
include a blind rater approach).  However, that the patients did not some improvement in 
terms of the symptoms that they thought important is encouraging.  
The current study was observational in nature, and inclusion of a comparison group is 
a future research goal.  This would allow investigation of the non-specific effects of 16 hours 
of contact with therapists.  However, the fact that the patients had not shown improvement 
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prior to their involvement in the RRST programme for a long period of time, suggests that it 
may be a useful adjunct to the pharmacological approach.  The mechanism of action of the 
RRST is still unclear, in that the patients continued on their course of medication during the 
treatment.  This leave open the possibilities that either the RRST programme was effective in 
its own right, or that it helped to produce greater adherence to the pharmacological regime.  It 
should be noted that the programme is complex, and it might be that not all components are 
needed.  That depression decreased more than anxiety is paradoxical given relaxation reduces 
arousal, and it may be that social support is a major active component of this procedure.  
Additionally, the results of the study could be developed by including the use of 
measurement of the target behaviours taught in the programme, inter-rater agreement on the 
clinician measures, and the addition of a longer-term follow up assessment.   
That the RRST programme was successful with patients who had previously 
demonstrated little change in their symptomatology through the use of pharmacological 
interventions is encouraging, and adds to the number of psychological supports that may be 
considered for this patient group (Wiles et al., 2013).  Thus, the current preliminary results 
suggest that this short-term RRST offers a simple and cost-effective way to augment 
management for the most common psychiatric disorders claimed in public health settings, as 
complementary intervention in case of patients less responsive to the drug treatment. 
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Table 1:  Mean (standard deviations) for overall symptoms (SCL-90), depression (BDI), 
and anxiety (STAI) for the sample pre and post treatment, as well as the mean change 
score (post minus pre) and the correlations between the change score and the 
participants age (Pearson) and gender (point biserial). 
 
--------------------------------------------------------------------------------------------------- 
Overall    Pre      Post      Change Age Gender     Change           d         
                                                                                                         t(39)                    
--------------------------------------------------------------------------------------------------- 
Symptom   94.13      66.05     -28.08  .316  -.079          5.63***    .893        
Number  (37.39)   (38.33)    (31.41)  
--------------------------------------------------------------------------------------------------- 
Depression    15.77     12.24        -3.53 .143  -.128          3.20**      .506          
(BDI)    (7.58)    (7.41)       (6.96)  
--------------------------------------------------------------------------------------------------- 
Depression   19.15     12.77       -6.35        .162      -.275           9.32***   1.475        
(Hamilton)     (5.95)    (5.27)       (4.31) 
--------------------------------------------------------------------------------------------------- 
Anxiety   53.33     49.25       -4.08 .261  -.001         2.92**       .461         
(STAI)              (11.56)  (10.51)     (8.84) 
--------------------------------------------------------------------------------------------------- 
Anxiety   18.00     11.18       -6.82       -.018     -.162           7.20***    1.140        
(Hamilton)        (5.90)    (4.99)      (5.99) 
--------------------------------------------------------------------------------------------------- 
 
* p < .05; ** p < .01; *** p < .001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                Relaxation response training -    21 
Table 2:  Mean (standard deviations) for overall symptoms (SCL-90), depression (BDI), 
and anxiety (STAI) for the sample pre and post treatment, as well as the mean change 
score (post minus pre) and the correlations between the change score and the 
participants age (Pearson) and gender (point biserial).  Also shown is the clinical 
significance change for depressed participants. 
 
----------------------------------------------------------------------------------------------------- 
Depressed  Pre    Post      Change Age   Gender     Change            d     
                                                                                                         t(39)                     
----------------------------------------------------------------------------------------------------- 
Symptom 92.71    57.88      -34.83  .543**    -.192         5.43***      1.109 
Number         (35.61)   (31.58)    (31.40)  
-----------------------------------------------------------------------------------------------------  
Depression  15.92     13.17        -2.75 .158    -.130        1.94*            .396              
(BDI)  (7.76)   (8.43)       (6.95)  
----------------------------------------------------------------------------------------------------- 
Depression 19.83    12.88       -6.96         .078       -.229        8.10***      1.658   
(Hamilton)   (5.70)     (6.05)       (4.21) 
----------------------------------------------------------------------------------------------------- 
Anxiety 53.00    48.17       -4.83         .497    -.240        3.37**          .688   
(STAI)            (10.41)    (9.50)      (7.02) 
----------------------------------------------------------------------------------------------------- 
Anxiety 18.46      10.54       -7.92        -.025        -.224        7.22***      1.475            
(Hamilton)      (6.64)      (4.73)      (5.37) 
------------------------------------------------------------------------------------------------------ 
 
* p < .05; ** p < .01; *** p < .001 
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Table 3:  Mean (standard deviations) for overall symptoms (SCL-90), depression (BDI), 
and anxiety (STAI) for the sample pre and post treatment, as well as the mean change 
score (post minus pre) and the correlations between the change score and the 
participants age (Pearson) and gender (point biserial).  Also shown is the clinical 
significance change for anxious participants. 
 
 
----------------------------------------------------------------------------------------------------- 
Anxious  Pre    Post      Change Age   Gender     Change          d       
                                                                                                         t(39)                     
----------------------------------------------------------------------------------------------------- 
Symptom 96.25    78.31      -17.94  .014    -.005           2.43*        .609   
Number         (41.02)   (44.98)    (29.48)  
----------------------------------------------------------------------------------------------------  
Depression  15.56     10.88        -4.69 .145    -.072           2.66*        .666   
(BDI)  (7.56)   (5.52)       (7.04)  
----------------------------------------------------------------------------------------------------- 
Depression 18.06   12.62        -5.44        .250        -.460            4.91***   1.234 
(Hamilton)   (6.33)     (4.02)       (4.42) 
------------------------------------------------------------------------------------------------------ 
Anxiety 53.81    50.88       -2.94 .073    -.239            1.05          .376             
(STAI)            (13.46)   (11.99)     (11.20) 
------------------------------------------------------------------------------------------------------- 
Anxiety 17.31      12.13       -5.19       -.036        -.188           3.12**      .779       
(Hamilton)      (4.70)      (5.38)      (6.65) 
-------------------------------------------------------------------------------------------------------- 
 
* p < .05; ** p < .01; *** p < .001 
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Table 4: Percentage of participants in overall sample, and with depression or anxiety 
disorders, showing improvement according to four criterion: actual = change in raw 
score; reliable = statistically reliable change; cut-off = decreasing from above to below 
scale cut-off point; and clinical = decrease from above to below point for clinical 
significance. 
 
------------------------------------------------------------------------------ 
                                           Actual      Reliable    Cut-off      Clinical 
------------------------------------------------------------------------------  
SCL-90 Sample               87.5          27.5          48.4           39.4 
               Depressed          91.7          37.5          66.7           50.0  
                  Anxious             81.3          12.5          23.1           23.1 
------------------------------------------------------------------------------             
BDI       Sample              65.0          25.0          46.4           25.0  
                          Depressed         62.5          25.0          43.8           25.0  
                          Anxious            68.8          25.0          50.0           25.0             
------------------------------------------------------------------------------ 
HAMD   Sample            92.5          67.5          17.9           12.8 
                Depressed        95.8          70.8          25.0          16.7 
                  Anxious           87.5          62.5            6.7            6.7     
------------------------------------------------------------------------------- 
STAI      Sample             62.5          35.0              6.5           0  
                   Depressed        79.2          37.5             10.5          0 
                  Anxious           37.5          31.3               0             0             
------------------------------------------------------------------------------- 
HAMA   Improve           90.0          52.5            47.4        63.2 
                Depressed        95.8          58.3            52.2        69.6 
                  Anxious            81.3          43.8            40.0        53.3 
-------------------------------------------------------------------------------           
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Figure 1.  Mean change score per item for the subscales of the SCL-90 for the overall 
sample, and for the participants with either a depressive or anxiety disorder. 
 
 
 
 
 
 
 
 
 
 
 
 
 
